Holen Sie sich die Stockscreener-App
7.16
7.17%
0.47
Schlusskurs vom Vortag:
$6.69
Offen:
$6.69
24-Stunden-Volumen:
174.41K
Relative Volume:
0.44
Marktkapitalisierung:
$480.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-122.44M
KGV:
-3.1766
EPS:
-2.254
Netto-Cashflow:
$-103.79M
1W Leistung:
+16.02%
1M Leistung:
-17.40%
6M Leistung:
-5.66%
1J Leistung:
+59.33%
1-Tages-Spanne:
$6.69
$7.25
1-Wochen-Bereich:
$6.29
$7.25
52-Wochen-Spanne:
$2.65
$12.25
Engene Holdings Inc Stock (ENGN) Company Profile
Firmenname
Engene Holdings Inc
Sektor
Branche
Telefon
(514) 332-4888
Adresse
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
7.17 | 448.16M | 0 | -122.44M | -103.79M | -2.254 |
VRTX
Vertex Pharmaceuticals Inc
|
433.56 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.84 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.14 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.59 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.86 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | Jefferies | Buy |
| 2025-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-14 | Herabstufung | UBS | Buy → Neutral |
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-27 | Eingeleitet | Raymond James | Outperform |
| 2024-11-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-03-28 | Eingeleitet | UBS | Buy |
| 2024-03-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten
Three new option listings and three option delistings on April 6th - tipranks.com
Aug Intraday: How does enGene Holdings Inc compare to its peers2026 Buyback Activity & Safe Capital Preservation Plans - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN) - The Globe and Mail
enGene Holdings Inc (ENGN) Income Statement - tradingkey.com
Market Leaders: What analysts say about enGene Holdings Inc Equity Warrant stockDollar Strength & High Accuracy Trade Alerts - baoquankhu1.vn
ENGNW SEC FilingsForbion European Acquisition Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Tangible book value per share of enGene Holdings Inc. – NASDAQ:ENGNW - TradingView
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Down 25.3% in March - MarketBeat
Bull Run: Why is enGene Holdings Inc Equity Warrant stock going upQuarterly Profit Summary & Daily Entry Point Alerts - baoquankhu1.vn
Setup Watch: What are the analyst revisions for enGene Holdings IncIs FACT stock a good investment in YEARInflation Watch & Community Consensus Trade Alerts - baoquankhu1.vn
Energy Moves: Is enGene Holdings Inc Equity Warrant impacted by rising ratesMarket Sentiment Review & Precise Trade Entry Recommendations - baoquankhu1.vn
enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Sentiment Watch: Is enGene Holdings Inc Equity Warrant stock a value trapPortfolio Update Report & Technical Confirmation Trade Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: enGene Holdings (ENGN) and Boston Scientific (BSX) - The Globe and Mail
UBS cuts Engene Holdings stock price target on trial costs - Investing.com UK
UBS cuts Engene Holdings stock price target on trial costs By Investing.com - Investing.com South Africa
Volume Recap: Can enGene Holdings Inc Equity Warrant lead its sector in growth2026 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn
Bank Watch: Is enGene Holdings Inc a stock for growth or value investors2026 Short Interest & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Sell Signal: How does enGene Holdings Inc compare to its peersQuarterly Risk Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Valuation Update: What analysts say about enGene Holdings Inc Equity Warrant stock2026 Snapshot & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Bank Watch: Is enGene Holdings Inc Equity Warrants ROE strong enough2026 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
ENGN PE Ratio & Valuation, Is ENGN Overvalued - Intellectia AI
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care - The Globe and Mail
enGene CEO Pitches Detalimogene as Community-Friendly NMIBC Option, Teases Q2 LEGEND Data Update - MarketBeat
enGene Shares Detalimogene NMIBC Trial Changes, FDA Endpoint Shift, and 2027 Approval Path at Conference - MarketBeat
Portfolio Update: Is enGene Holdings Inc stock a good dividend stock2026 Performance Recap & Community Trade Idea Sharing Platform - baoquankhu1.vn
Aug Reactions: Why is enGene Holdings Inc Equity Warrant stock going up2026 EndofYear Setup & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Short Interest in enGene Holdings Inc. (NASDAQ:ENGN) Decreases By 17.7% - MarketBeat
enGene Highlights 2026 Data Catalysts, BLA Plans for Bladder Cancer Gene Therapy at Barclays Conference - MarketBeat
Braidwell LP Invests $15.48 Million in enGene Holdings Inc. $ENGN - MarketBeat
enGene (NASDAQ:ENGN) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Oppenheimer Issues Pessimistic Forecast for enGene (NASDAQ:ENGN) Stock Price - Defense World
Merger Talk: Can enGene Holdings Inc Equity Warrant lead its sector in growth2026 Key Highlights & Reliable Price Action Trade Plans - baoquankhu1.vn
AI Stocks: Will enGene Holdings Inc stock benefit from M A2026 Short Interest & Entry and Exit Point Strategies - baoquankhu1.vn
enGene Holdings: Key Catalysts Incoming For 2026 (NASDAQ:ENGN) - Seeking Alpha
enGene (NASDAQ:ENGN) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Citizens reiterates Engene Holdings stock rating on BLA timeline By Investing.com - Investing.com South Africa
HC Wainwright Has Optimistic Outlook of enGene Q2 Earnings - MarketBeat
Citizens reiterates Engene Holdings stock rating on BLA timeline - Investing.com
FY2030 Earnings Forecast for enGene Issued By HC Wainwright - Defense World
enGene Shares Gain 5% After Bladder Cancer Therapy Shows Stronger Response Rates - MSN
enGene (NASDAQ:ENGN) Price Target Lowered to $30.00 at Oppenheimer - MarketBeat
Pullback Watch: How does enGene Holdings Inc compare to its peers2026 Highlights & Weekly High Return Opportunities - baoquankhu1.vn
ENGN: Detalimogene offers promising efficacy and convenience for NMIBC, with pivotal data updates ahead - TradingView
HC Wainwright Has Positive Outlook of enGene FY2030 Earnings - MarketBeat
enGene Holdings (ENGN) Gets a Buy from Wells Fargo - The Globe and Mail
Smart Money: Can SIFCO Industries Inc continue delivering strong returns2026 Momentum & Stepwise Trade Signal Guides - baoquankhu1.vn
ENGN: Detalimogene's pivotal data and unique profile position it to transform NMIBC treatment - TradingView
enGene (NASDAQ:ENGN) Posts Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat
ENGN: Detalimogene offers a unique, highly tolerable NMIBC therapy with pivotal data updates in 2024 - TradingView
Engene stock price target lowered to $27 by Guggenheim on estimates - za.investing.com
Finanzdaten der Engene Holdings Inc-Aktie (ENGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):